Search results for "new drug candidates"

New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily on a distinct "optimal...
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a chemistry lab, but at a major...
Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Pancreatic cancer carries a five-year relative survival rate of just 17.0%, the lowest among all major cancers,...
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital

‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital

Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform

AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform

Antibody-drug conjugate developer AbTis announced on August 14 that it has prevailed in an inter partes review before...
AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy

AI Platform Replaces Animal Models to Accelerate Parkinson’s Cell Therapy

Researchers are launching an international joint study that leverages artificial intelligence to evaluate whether...
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...